NCT00346164 2022-04-28
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Children's Oncology Group
Phase 3 Completed
Children's Oncology Group
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)